Mirae Asset Global Etfs Holdings Ltd. Iovance Biotherapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 154,697 shares of IOVA stock, worth $361,990. This represents 0.0% of its overall portfolio holdings.
Number of Shares
154,697
Previous 182,791
15.37%
Holding current value
$361,990
Previous $608,000
56.25%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding IOVA
# of Institutions
286Shares Held
233MCall Options Held
1.12MPut Options Held
1.15M-
Mhr Fund Management LLC New York, NY29MShares$67.8 Million8.78% of portfolio
-
Vanguard Group Inc Valley Forge, PA25.1MShares$58.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$49.7 Million0.0% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR11.8MShares$27.7 Million0.94% of portfolio
-
State Street Corp Boston, MA9.89MShares$23.1 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $369M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...